Enhance your nephrology practice with CME and tools focused on kidney medicine.
Difelikefalin: Managing CKD-aP for Improved Quality of Life
Jörg Latus, MD
Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies
Jürgen Floege, MD
Michelle O’Shaughnessy, MD, MBBCh
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Precision Medicine in IgAN: A Deep Dive Into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
September 19, 2025
Prague
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Andreas Kronbichler, MD
Managing Patients With AAV in the Rheumatology Clinic
Don't Miss It! Rapid & Accurate AAV Diagnosis
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Optimizing AAV Outcomes: Maintenance Therapies
Elevating Care for Patients With Severe Renal Disease in AAV
Unmasking IgAN: From Suspicion to Timely Diagnosis
Chee Kay Cheung, MBCHB, MRCP, PHD
Advances in IgAN Care From Kidney Week
Sydney Tang, MBBS, MD
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jonathan Barratt, MD, PhD
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
James Burton, DM, FRCP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.